USpharma
FDA Approved Drugs

USpharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 7
  • Latest Approval Date Feb 09, 2026
  • Data Source FDA
  • First Approval Date Apr 04, 1995
Company Overview

Company

USpharma

Country

U.S.A

Social Profiles

Company Snapshot

USpharma

13900 NW 57th Court Miami Lakes, FL 33014

U.S.A

www.uspharmaltd.com/ info@uspharmaltd.com View on Map
FDA Approved Drug Records ( 7 records )
2026
09 Feb
RX Application: 207059

Drug Name

LIDOCAINE

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2026-02-09

207059 / 1

Active Ingredient

LIDOCAINE

Application Number

207059

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2026-02-09

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

1

Dosage Form

-

Strength

0.1MG/HR

Approval Date

1995-04-04

20145 / 1

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

1

Dosage Form

-

Strength

0.1MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

2

Dosage Form

-

Strength

0.2MG/HR

Approval Date

1995-04-04

20145 / 2

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

2

Dosage Form

-

Strength

0.2MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

3

Dosage Form

-

Strength

0.3MG/HR

Approval Date

1995-04-04

20145 / 3

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

3

Dosage Form

-

Strength

0.3MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

4

Dosage Form

-

Strength

0.4MG/HR

Approval Date

1995-04-04

20145 / 4

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

4

Dosage Form

-

Strength

0.4MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

5

Dosage Form

-

Strength

0.6MG/HR

Approval Date

1995-04-04

20145 / 5

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

5

Dosage Form

-

Strength

0.6MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

1995
04 Apr
RX Application: 20145

Drug Name

NITRO-DUR

Product Number

6

Dosage Form

-

Strength

0.8MG/HR

Approval Date

1995-04-04

20145 / 6

Active Ingredient

NITROGLYCERIN

Application Number

20145

Product Number

6

Dosage Form

-

Strength

0.8MG/HR

Approval Date

1995-04-04

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    7 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
7 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

LIDOCAINE

Application Number

207059

Product Number

1

Active Ingredient

LIDOCAINE

Dosage Form

-

Strength

5%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.